Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a global biopharmaceutical company, on 25 march announced that the Foundation Fighting Blindness (Foundation), a national nonprofit driving sight-saving research, will honor Sucampo’s Co-Founder and Chairman Emeritus, Ryuji Ueno, M.D., Ph.D., Ph.D., with the Foundation’s Visionary Award, in recognition of Dr. Ueno’s longstanding commitment to helping patients with eye diseases. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) shares after opening at $6.67 moved to $6.84 on last trade day and at the end of the day closed at $6.75. Company price to sales ratio in past twelve months was calculated as 3.31 and price to cash ratio as 4.94. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) showed a negative weekly performance of -0.30%.
SEACOR Holdings Inc. (NYSE:CKH) announced that Richard J. Ryan, the Company’s Senior Vice President, Chief Financial Officer, has communicated his intention to retire from the Company, effective as of August 1, 2014, after a highly successful seventeen year career with the Company. Seacor Holdings, Inc. (NYSE:CKH) shares fell -4.54% in last trading session and ended the day on $83.25. CKH return on equity ratio is recorded as 2.70% and its return on assets is 1.30%. Seacor Holdings, Inc. (NYSE:CKH) yearly performance is 14.61%.
American Midstream Partners, LP. (NYSE:AMID) announced that the board of directors of its general partner declared a quarterly cash distribution of $0.4625 per unit for the first quarter ended March 31, 2014, or $1.85 per unit on an annualized basis. American Midstream Partners LP (NYSE:AMID) shares moved up 0.82% in last trading session and was closed at $27.15, while trading in range of $26.75 – $27.15. American Midstream Partners LP (NYSE:AMID) year to date (YTD) performance is 1.99%.
Illumina (NASDAQ:ILMN) announced on 25 April that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc.Illumina is seeking all available remedies, including injunctive relief. Illumina, Inc. (NASDAQ:ILMN) weekly performance is 3.15%. On last trading day company shares ended up $139.71. Illumina, Inc. (NASDAQ:ILMN) distance from 50-day simple moving average (SMA50) is -11.05%. Analysts mean target price for the company is $176.97.
Leave a Reply